Free Float 39,21 %
Shares Float 245,64 M
Shares Outstanding 626,54 M
E-THERAPEUTICSCS PLC Share · GB00B2823H99 · A0M8VQ (XLON) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of E-THERAPEUTICSCS PLC
No Price
Share Float & Liquidity
Company Profile for E-THERAPEUTICSCS PLC Share
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.
Company Data
Name E-THERAPEUTICSCS PLC
Company E-therapeutics Plc
Website
https://www.etherapeutics.co.uk
Primary Exchange 
London
London
WKN A0M8VQ
ISIN GB00B2823H99
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Ahmad Ali Mortazavi
Market Capitalization 56 Mio
Country United Kingdom
Currency GBP
Employees 0,0 T
Address 4 Kingdom Street, W2 6BD London
IPO Date 2007-11-28
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | ETXPF |
| London | ETX.L |
More Shares
Investors who hold E-THERAPEUTICSCS PLC also have the following shares in their portfolio:
